Annual Operating Profit
-$49.60 M
-$24.70 M-99.20%
31 December 2023
Summary:
Zevra Therapeutics annual operaing income is currently -$49.60 million, with the most recent change of -$24.70 million (-99.20%) on 31 December 2023. During the last 3 years, it has fallen by -$44.82 million (-937.52%). ZVRA annual operating profit is now -741.79% below its all-time high of $7.73 million, reached on 31 December 2021.ZVRA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$27.31 M
-$3.51 M-14.76%
30 September 2024
Summary:
Zevra Therapeutics quarterly operating income is currently -$27.31 million, with the most recent change of -$3.51 million (-14.76%) on 30 September 2024. Over the past year, it has dropped by -$11.94 million (-77.73%). ZVRA quarterly operating profit is now -492.33% below its all-time high of $6.96 million, reached on 01 March 2021.ZVRA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$86.74 M
-$11.94 M-15.96%
30 September 2024
Summary:
Zevra Therapeutics TTM operating income is currently -$86.74 million, with the most recent change of -$11.94 million (-15.96%) on 30 September 2024. Over the past year, it has dropped by -$42.98 million (-98.23%). ZVRA TTM operating profit is now -1137.11% below its all-time high of $8.36 million, reached on 01 June 2021.ZVRA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.2% | -77.7% | -98.2% |
| 3 y3 years | -937.5% | -1128.9% | -1279.4% |
| 5 y5 years | +8.6% | -944.3% | -244.3% |
ZVRA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -741.8% | at low | -1368.8% | at low | -1222.3% | at low |
| 5 y | 5 years | -741.8% | +8.6% | -492.3% | at low | -1137.1% | at low |
| alltime | all time | -741.8% | +8.6% | -492.3% | at low | -1137.1% | at low |
Zevra Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$27.31 M(+14.8%) | -$86.74 M(+16.0%) |
| June 2024 | - | -$23.80 M(+16.2%) | -$74.80 M(+30.6%) |
| Mar 2024 | - | -$20.49 M(+35.2%) | -$57.26 M(+15.4%) |
| Dec 2023 | -$49.60 M(+99.2%) | -$15.16 M(-1.3%) | -$49.60 M(+13.4%) |
| Sept 2023 | - | -$15.36 M(+145.7%) | -$43.76 M(+25.0%) |
| June 2023 | - | -$6.25 M(-51.3%) | -$35.02 M(-34.6%) |
| Mar 2023 | - | -$12.83 M(+37.8%) | -$53.54 M(+25.8%) |
| Dec 2022 | -$24.90 M(-422.2%) | -$9.31 M(+40.6%) | -$42.56 M(+17.9%) |
| Sept 2022 | - | -$6.63 M(-73.2%) | -$36.09 M(+13.9%) |
| June 2022 | - | -$24.77 M(+1232.3%) | -$31.69 M(+2807.3%) |
| Mar 2022 | - | -$1.86 M(-34.6%) | -$1.09 M(-114.1%) |
| Dec 2021 | $7.73 M(-261.7%) | - | - |
| Dec 2021 | - | -$2.84 M(+27.9%) | $7.73 M(+5.1%) |
| Sept 2021 | - | -$2.22 M(-138.1%) | $7.36 M(-12.1%) |
| June 2021 | - | $5.83 M(-16.2%) | $8.36 M(+63.2%) |
| Mar 2021 | - | $6.96 M(-316.4%) | $5.12 M(-207.2%) |
| Dec 2020 | -$4.78 M(-76.5%) | -$3.22 M(+165.1%) | -$4.78 M(-20.0%) |
| Sept 2020 | - | -$1.21 M(-146.8%) | -$5.97 M(+291.0%) |
| June 2020 | - | $2.59 M(-188.0%) | -$1.53 M(-87.2%) |
| Mar 2020 | - | -$2.94 M(-33.2%) | -$11.91 M(-41.4%) |
| Dec 2019 | -$20.34 M | -$4.41 M(-236.4%) | -$20.34 M(-19.3%) |
| Sept 2019 | - | $3.23 M(-141.5%) | -$25.20 M(-43.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$7.79 M(-31.5%) | -$44.75 M(-12.0%) |
| Mar 2019 | - | -$11.37 M(+22.7%) | -$50.87 M(-6.3%) |
| Dec 2018 | -$54.27 M(+62.6%) | -$9.27 M(-43.2%) | -$54.27 M(+2.1%) |
| Sept 2018 | - | -$16.32 M(+17.4%) | -$53.15 M(+14.4%) |
| June 2018 | - | -$13.91 M(-5.8%) | -$46.44 M(+13.9%) |
| Mar 2018 | - | -$14.77 M(+81.2%) | -$40.76 M(+22.1%) |
| Dec 2017 | -$33.37 M(-3.2%) | -$8.15 M(-15.2%) | -$33.37 M(-7.5%) |
| Sept 2017 | - | -$9.61 M(+16.9%) | -$36.05 M(+6.6%) |
| June 2017 | - | -$8.22 M(+11.4%) | -$33.83 M(-3.0%) |
| Mar 2017 | - | -$7.38 M(-31.9%) | -$34.88 M(+1.2%) |
| Dec 2016 | -$34.47 M(+51.1%) | -$10.84 M(+46.6%) | -$34.47 M(+11.5%) |
| Sept 2016 | - | -$7.39 M(-20.3%) | -$30.92 M(+3.0%) |
| June 2016 | - | -$9.28 M(+33.1%) | -$30.01 M(+12.4%) |
| Mar 2016 | - | -$6.97 M(-4.3%) | -$26.69 M(+17.0%) |
| Dec 2015 | -$22.81 M(+38.7%) | -$7.28 M(+12.4%) | -$22.81 M(-0.9%) |
| Sept 2015 | - | -$6.48 M(+8.8%) | -$23.02 M(+10.3%) |
| June 2015 | - | -$5.96 M(+92.4%) | -$20.88 M(+16.2%) |
| Mar 2015 | - | -$3.10 M(-58.7%) | -$17.97 M(+9.3%) |
| Dec 2014 | -$16.44 M(+248.5%) | -$7.49 M(+72.6%) | -$16.44 M(+83.6%) |
| Sept 2014 | - | -$4.34 M(+42.5%) | -$8.96 M(+94.0%) |
| June 2014 | - | -$3.04 M(+93.7%) | -$4.62 M(+193.7%) |
| Mar 2014 | - | -$1.57 M | -$1.57 M |
| Dec 2013 | -$4.72 M | - | - |
FAQ
- What is Zevra Therapeutics annual operaing income?
- What is the all time high annual operating profit for Zevra Therapeutics?
- What is Zevra Therapeutics annual operating profit year-on-year change?
- What is Zevra Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly operating profit year-on-year change?
- What is Zevra Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Zevra Therapeutics?
- What is Zevra Therapeutics TTM operating profit year-on-year change?
What is Zevra Therapeutics annual operaing income?
The current annual operating profit of ZVRA is -$49.60 M
What is the all time high annual operating profit for Zevra Therapeutics?
Zevra Therapeutics all-time high annual operaing income is $7.73 M
What is Zevra Therapeutics annual operating profit year-on-year change?
Over the past year, ZVRA annual operaing income has changed by -$24.70 M (-99.20%)
What is Zevra Therapeutics quarterly operating income?
The current quarterly operating profit of ZVRA is -$27.31 M
What is the all time high quarterly operating profit for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly operating income is $6.96 M
What is Zevra Therapeutics quarterly operating profit year-on-year change?
Over the past year, ZVRA quarterly operating income has changed by -$11.94 M (-77.73%)
What is Zevra Therapeutics TTM operating income?
The current TTM operating profit of ZVRA is -$86.74 M
What is the all time high TTM operating profit for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM operating income is $8.36 M
What is Zevra Therapeutics TTM operating profit year-on-year change?
Over the past year, ZVRA TTM operating income has changed by -$42.98 M (-98.23%)